ABBOTT LABORATORIES acquires Vysis, Inc.
Snapshot
ABBOTT LABORATORIES acquired Vysis, Inc. for $30.50 per share in cash (approximately $355 million) in December 2001. The transaction was structured as all cash (tender offer and merger). Vysis, Inc. is a Downers Grove, Illinois, USA-based Diagnostics — molecular / genomic diagnostics business.
- Acquirer
- ABBOTT LABORATORIES
- Target
- Vysis, Inc.
- Value
- $30.50 per share in cash (approximately $355 million)
- Date
- December 2001
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
ABBOTT LABORATORIES acquired Vysis, Inc. for $30.50 per share in cash (approximately $355 million), a transaction completed in December 2001, structured as all cash (tender offer and merger).
Vysis, Inc. operates in Diagnostics — molecular / genomic diagnostics, is based in Downers Grove, Illinois, USA. Vysis is a genomic disease management company specializing in molecular cytogenetic and FISH-based diagnostic products for cancer and genetic disease.
Adds molecular and genomic diagnostic capabilities to Abbott's diagnostics franchise.
Pioneering molecular/FISH diagnostic technology that became the basis of Abbott Molecular. Became part of Abbott Molecular / Abbott Diagnostics
No advisory firms have been disclosed for this transaction.